In the new round of shuffling war, what kind of situation are pharmaceutical equipment enterprises facing?

[market analysis of chinapharma.com] from the current development of the pharmaceutical industry, whether it is drug bidding, medical insurance and fee control, or consistency evaluation, environmental protection policies, pharmaceutical enterprises will adjust their product structure to meet the market demand However, there are still many pharmaceutical companies in the situation that they can't adapt to the adjustment and can't keep up with their own reform, they choose to sell or seek cooperation If they succeed, these pharmaceutical enterprises can continue to develop; if they fail, they will be out of the business, or even not at all Industry analysts said that in this round of reshuffle, only 1000 domestic pharmaceutical companies are left For the pharmaceutical equipment industry, which is highly valued by all walks of life, it will also be greatly affected by the shuffling war It is reported that since 2018, the drug production license of 140 drug manufacturers in 12 provinces has been cancelled At present, the shuffling war in the pharmaceutical industry continues What kind of situation will pharmaceutical equipment enterprises face in the new round of shuffling war? (what kind of situation will pharmaceutical equipment enterprises face in the new round of shuffling war? Photo source: China Pharmaceutical network) pharmaceutical equipment industry is an important link in pharmaceutical production For the new round of shuffling war, experts say that the strength of Chinese pharmaceutical equipment enterprises is constantly improving, but there is a fact that can not be ignored that there are more than ten, dozens, or even hundreds of similar product manufacturers Not only that, the production standards among enterprises are not uniform, and the overall level is uneven In the future, the development direction of the industry will be mainly refined and simplified In addition, affected by the shuffling war of pharmaceutical enterprises, pharmaceutical equipment enterprises with high product repetition and no core competitiveness will inevitably be eliminated In addition to the above reasons, the insiders also believe that the manufacturing level of domestic equipment can only meet some links, and in many cases it is difficult to provide the whole production line with supporting production, and the part with high profits is often divided by overseas enterprises In addition, the awareness of production management of domestic pharmaceutical enterprises is backward, and the awareness of actively improving production line to improve product quality and production efficiency is insufficient In this case, if the pharmaceutical equipment enterprises have not taken relevant practical actions, they can only become a member of the elimination team In fact, it's not just the shuffling war Since 2016, the relevant policies of the state, including the policy of replacing business tax with value-added tax, the two vote system, the price reduction of medical consumables and other policies, have accelerated the shuffling of the industry, and many pharmaceutical equipment enterprises have taken measures to deal with it For example, under the policy support of the localization of pharmaceutical equipment encouraged by the state, some enterprises mainly produce pharmaceutical equipment, vigorously introduce skilled and R & D-oriented high-tech talents, strengthen the construction of talent team, establish a perfect modern enterprise system, and provide a strong talent reserve for the transformation of pharmaceutical equipment And powerful pharmaceutical companies are increasingly not considering winning the bid for low-cost pharmaceutical equipment, that is to say, pharmaceutical companies are moving forward This also makes the manufacturing and R & D direction more clear for pharmaceutical equipment enterprises: low-end, weak product pharmaceutical enterprises will not favor, strong equipment products are the choice of pharmaceutical enterprises In addition, the increasingly strict industry supervision is also a major trend According to the analysis of the insiders, the standardized pharmaceutical equipment enterprises in the industry are expected to be strong, because the state has increased the inspection of the pharmaceutical equipment industry since a few years ago Enterprises with irregular production and operation will gradually be cleared out of the market, while leading enterprises with standardized operation will gain more market share In general, the shuffling war in the pharmaceutical industry will last for a long time, and more and more pharmaceutical enterprises will be eliminated Affected by this, the situation faced by pharmaceutical equipment enterprises is not very optimistic Not only will pharmaceutical enterprises put forward higher and stricter equipment requirements, but also the development team of the whole industry will be increasingly refined and simplified Therefore, for pharmaceutical equipment enterprises, all we need to do is to introduce new concepts and concepts, use the current market-oriented operation mode to promote the better development of enterprises; we need to know the current and future industry trends, be prepared, actively adjust development strategies, and invest more and more advanced equipment products for the market, pharmaceutical enterprises and patients.